Literature DB >> 1315175

Liver-cell dysplasia and hepatocellular carcinoma.

M Podda1, M Roncalli, P M Battezzati, M Borzio, S Bruno, E Servida, G Coggi.   

Abstract

Liver-cell dysplasia is a well known histological entity with preneoplastic significance in experimental hepatic carcinogenesis. However, while the association of liver-cell dysplasia with hepatitis B virus can be considered as established, it is still controversial whether this lesion represents a premalignant condition in cirrhotic patients. Efforts have been made to render its morphological assessment more reliable, but no firm conclusions can be drawn from the available clinical studies, which are mainly retrospective or based on autopsy series. Preliminary results from a prospective study argue that liver-cell dysplasia is associated with an increased risk to hepatocellular carcinoma. The emergence of liver-cell dysplasia as a preneoplastic lesion in cirrhotic patients will have some impact in the future on their management, including selection for closer monitoring in early detection of hepatocellular carcinoma and for liver transplantation.

Entities:  

Mesh:

Year:  1992        PMID: 1315175

Source DB:  PubMed          Journal:  Ital J Gastroenterol        ISSN: 0392-0623


  3 in total

Review 1.  The status of zinc in the development of hepatocellular cancer: an important, but neglected, clinically established relationship.

Authors:  Leslie C Costello; Renty B Franklin
Journal:  Cancer Biol Ther       Date:  2014-01-21       Impact factor: 4.742

2.  ZIP14 zinc transporter downregulation and zinc depletion in the development and progression of hepatocellular cancer.

Authors:  Renty B Franklin; Bernard A Levy; Jing Zou; Nader Hanna; Mohamed Mokhtar Desouki; Omar Bagasra; Leslie A Johnson; Leslie C Costello
Journal:  J Gastrointest Cancer       Date:  2012-06

3.  Comparative histomorphological review of rat and human hepatocellular proliferative lesions.

Authors:  Bob Thoolen; Fiebo J W Ten Kate; Paul J van Diest; David E Malarkey; Susan A Elmore; Robert R Maronpot
Journal:  J Toxicol Pathol       Date:  2012-10-01       Impact factor: 1.628

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.